Literature DB >> 17530260

Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Cristiane Murta-Nascimento1, Bernd J Schmitz-Dräger, Maurice P Zeegers, Gunnar Steineck, Manolis Kogevinas, Francisco X Real, Núria Malats.   

Abstract

Urinary bladder cancer (UBC) ranks ninth in worldwide cancer incidence. It is more frequent in men than in women. We review the main established/proposed factors, both environmental and genetic, associated with bladder cancer etiology and prognosis. Data were extracted from previous reviews and original articles identified from PubMed searches, reference lists, and book chapters dealing with the reviewed topics. Evaluation and consensus of both the contribution of each factor in bladder cancer burden and the appropriateness of the available evidences was done during an ad hoc meeting held during the 18th Congress of the European Society for Urological Research. Cigarette smoking and specific occupational exposures are the main known causes of UBC. Phenacetin, chlornaphazine and cyclophosphamide also increase the risk of bladder cancer. Chronic infection by Schistosoma haematobium is a cause of squamous cell carcinoma of the bladder. NAT2 slow acetylator and GSTM1 null genotypes are associated with an increased risk of this cancer. Vegetables and fresh fruits protect against this tumor. Regarding prognosis, there is little knowledge on the predictive role of environmental exposures and genetic polymorphisms on tumor recurrence and progression and patient's death. Although active tobacco smoking is the most commonly studied factor, no definitive conclusion can be drawn from the literature. More research is needed regarding the effect of complex etiological factors in bladder carcinogenesis. Subgroup analysis according to stage, grade, and molecular features may help in identifying specific etiological and prognostic factors involved in different bladder cancer progression pathways.

Entities:  

Mesh:

Year:  2007        PMID: 17530260     DOI: 10.1007/s00345-007-0168-5

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   3.661


  182 in total

1.  Are tobacco use and urine pH indicated as risk factors for bladder carcinoma?

Authors:  S Wada; R Yoshimura; C Masuda; T Hase; S Ikemoto; T Kishimoto; S Fukushima
Journal:  Int J Urol       Date:  2001-03       Impact factor: 3.369

Review 2.  Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer.

Authors:  T R Griffiths; J K Mellon
Journal:  BJU Int       Date:  2000-01       Impact factor: 5.588

3.  Coffee, tea, mate, methylxanthines and methylglyoxal. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 27 February to 6 March 1990.

Authors: 
Journal:  IARC Monogr Eval Carcinog Risks Hum       Date:  1991

4.  Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study.

Authors:  Giuseppe Matullo; Simonetta Guarrera; Carlotta Sacerdote; Silvia Polidoro; Laura Davico; Sara Gamberini; Margaret Karagas; Giovanni Casetta; Luigi Rolle; Alberto Piazza; Paolo Vineis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-11       Impact factor: 4.254

5.  Cancer mortality following radium treatment for uterine bleeding.

Authors:  P D Inskip; R R Monson; J K Wagoner; M Stovall; F G Davis; R A Kleinerman; J D Boice
Journal:  Radiat Res       Date:  1990-09       Impact factor: 2.841

6.  p53 and MDM2 in the development and progression of bladder cancer.

Authors:  B J Schmitz-Dräger; M Kushima; P Goebell; T W Jax; C D Gerharz; H Bültel; W A Schulz; T Ebert; R Ackermann
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

7.  Acetaminophen and renal and bladder cancer.

Authors:  L E Derby; H Jick
Journal:  Epidemiology       Date:  1996-07       Impact factor: 4.822

8.  Cigarette smoking, tumor recurrence, and survival from bladder cancer.

Authors:  A M Michalek; K M Cummings; J E Pontes
Journal:  Prev Med       Date:  1985-01       Impact factor: 4.018

9.  Life time occupation, smoking, caffeine, saccharine, hair dyes and bladder carcinogenesis.

Authors:  G R Najem; D B Louria; J J Seebode; I S Thind; J M Prusakowski; R B Ambrose; A R Fernicola
Journal:  Int J Epidemiol       Date:  1982-09       Impact factor: 7.196

10.  Physical activity and risk of cancer in middle-aged men.

Authors:  S G Wannamethee; A G Shaper; M Walker
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

View more
  80 in total

1.  Urinary bladder cancer risk factors in Egypt: a multicenter case-control study.

Authors:  Yun-Ling Zheng; Sania Amr; Doa'a A Saleh; Chiranjeev Dash; Sameera Ezzat; Nabiel N Mikhail; Iman Gouda; Iman Loay; Tamer Hifnawy; Mohamed Abdel-Hamid; Hussein Khaled; Beverly Wolpert; Mohamed A Abdel-Aziz; Christopher A Loffredo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-12-06       Impact factor: 4.254

Review 2.  The association of cruciferous vegetables intake and risk of bladder cancer: a meta-analysis.

Authors:  Ben Liu; Qiqi Mao; Yiwei Lin; Feng Zhou; Liping Xie
Journal:  World J Urol       Date:  2012-03-06       Impact factor: 4.226

3.  Combretastatin A-4 inhibits cell growth and metastasis in bladder cancer cells and retards tumour growth in a murine orthotopic bladder tumour model.

Authors:  Cheng-Huang Shen; Jia-Jen Shee; Jin-Yi Wu; Yi-Wen Lin; Jiann-Der Wu; Yi-Wen Liu
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis.

Authors:  Jingyuan Tang; Xiao Li; Xuping Jiang; Weizhang Xu; Zhen Xu; Wei Wang; Bianjiang Liu; Qiang Lv; Wei Zhang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Lower risk in parous women suggests that hormonal factors are important in bladder cancer etiology.

Authors:  Carol A Davis-Dao; Katherine D Henderson; Jane Sullivan-Halley; Huiyan Ma; Dee West; Yong-Bing Xiang; Manuela Gago-Dominguez; Mariana C Stern; J Esteban Castelao; David V Conti; Malcolm C Pike; Leslie Bernstein; Victoria K Cortessis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

6.  Population-specific GSTM1 copy number variation.

Authors:  R Stephanie Huang; Peixian Chen; Steve Wisel; Shiwei Duan; Wei Zhang; Edwin H Cook; Soma Das; Nancy J Cox; M Eileen Dolan
Journal:  Hum Mol Genet       Date:  2008-10-23       Impact factor: 6.150

7.  Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence.

Authors:  Sanaa Eissa; Samir F Zohny; Abdel-Rahman N Zekri; Tarek Mostafa El-Zayat; Amany M Maher
Journal:  Med Oncol       Date:  2009-12-11       Impact factor: 3.064

8.  MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis.

Authors:  Angeline S Andrew; Margaret R Karagas; Florian R Schroeck; Carmen J Marsit; Alan R Schned; Jason R Pettus; David A Armstrong; John D Seigne
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-30       Impact factor: 4.254

9.  Oncologic outcomes between open and robotic-assisted radical cystectomy: a propensity score matched analysis.

Authors:  Michael Ahdoot; Leanne Almario; Hiwot Araya; Jonas Busch; Simon Conti; Mark L Gonzalgo
Journal:  World J Urol       Date:  2014-01-28       Impact factor: 4.226

Review 10.  Tissue engineering for the oncologic urinary bladder.

Authors:  Tomasz Drewa; Jan Adamowicz; Arun Sharma
Journal:  Nat Rev Urol       Date:  2012-08-21       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.